The Woodrow Wilson National Fellowship Foundation

Nielsen BuzzMetrics delivers consumer insights and real-time market intelligence solutions. It offers brand metrics that helps clients to apply consumer-generated media to their businesses. The company provides a range of brand management and new product development services. Nielsen BuzzMetrics also offers campaign tracking and measurement solutions. It is a part of The Nielsen Company, which is a privately held company that conducts operations in more than 100 countries. The parent company serves several clients in the media, telecommunications and consumer packaged goods industries. It is one of the leading marketing and media information companies in the world. In addition, The Nielsen Company operates Nielsen Claritas and Nielsen IMS.

Trammell Crow Company in Princeton, NJ is a real estate development and investment firm with a focus on creating innovative and sustainable properties. With a commitment to quality and community impact, Trammell Crow Company strives to deliver exceptional real estate solutions that meet the needs of both tenants and investors. Generated from their business information

Covance, located in Princeton, NJ, offers trusted scientific laboratory services to navigate the complexities of drug development for biopharma companies. Their solutions inform every phase of development, supporting targeted therapeutic indications and emerging treatment modalities. With expertise in nonclinical development, Covance provides scientific knowledge in toxicology, pharmacology, and metabolism to propel drug development programs forward. They offer risk assessments, regulatory guidance, and program management to advance breakthrough medicines in various therapeutic areas. Covance's central laboratory services generate extensive clinical trial data globally, supporting trials in over 100 countries. They assist in defining clinically relevant indicators through biomarkers, genomics testing, and companion diagnostics, aiding in the discovery, development, and commercialization of next-generation therapeutics. Generated from the website content